2 The applicant ('GenRx') distributes a generic form of the perindopril erbumine salt. While that company has been licensed by Servier to sell the product, it will also be affected by doctors affixing the stamp to prescriptions. 25 Servier submits that the purpose of the stamp is to assist a doctor to make a clear and visible statement to the pharmacist that brand substitution is not permitted for Coversyl specifically. This may result in loss of sales that cannot be determined or quantified. GenRx seeks orders prohibiting further publication of the advertisement. The undertakings were only proffered during the hearing.